06 Nov Androgen-deprivation therapy (ADT) causes a TXNIP increase necessary for prostate cancer regression

Posted at 16:54h in CANCER METABOLISM by

ID: 03346

Authors: Alcon-Rodriguez, Sergio (1,2,3); Mayo, Juan C (1,2,3); Gonzalez-Menendez, Pedro (1,2,3); Hevia, David (1,2,3); Fernandez-Vega, Sheila (1,2,3); Sainz, Rosa M (1,2,3); Quiros-Gonzalez, Isabel (1,2,3)

Topic: CANCER METABOLISM